← 返回

具有额外 COX-2 表达的调节性 T 细胞是外阴癌患者的独立不良预后因素

英文原题:Regulatory T Cells with Additional COX-2 Expression Are Independent Negative Prognosticators for Vulvar Cancer Patients.

查看英文原题

Regulatory T Cells with Additional COX-2 Expression Are Independent Negative Prognosticators for Vulvar Cancer Patients.

PubMed 2022/04/22(内容时间) Int J Mol Sci Q1 · IF 5.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

外阴癌的发病率在过去几十年中持续上升。特别是近年来,年轻外阴癌患者的数量有所增加。因此,确定新的预后因素以及外阴癌治疗选择的需求更加明显。本研究的目的是分析COX-2阳性TIL(肿瘤浸润淋巴细胞)和单核细胞的流入及其对预后的影响。通过免疫荧光亚型分析,大多数表达COX-2的免疫细胞被鉴定为FOXP3阳性调节性T细胞。此外,同一肿瘤组织中的瘤周和瘤内巨噬细胞同时被检测为M2极化巨噬细胞。COX-2阳性免疫细胞是外阴癌患者长期总生存期的独立不良预后标志物。这些结果表明免疫细胞浸润对外阴癌患者的影响。因此,免疫细胞浸润和免疫检查点表达可能成为进一步研究外阴癌新治疗策略的有趣靶点。

展开英文摘要原文

Vulvar cancer incidence numbers have been steadily rising over the past decades. In particular, the number of young patients with vulvar cancer has recently increased.

Therefore, the need to identify new prognostic factors and, in addition, therapeutic options for vulvar carcinoma is more apparent. The aim of this study was to analyze the influx of COX-2 positive tumor-infiltrating lymphocytes and monocytes and their influence on prognosis. Using subtyping by immunofluorescence, the majority of COX-2 expressing immune cells were identified as FOXP3-positive regulatory T cells.

In addition, peri- and intra-tumoral macrophages in the same tumor tissue were detected simultaneously as M2-polarized macrophages. COX-2 positive immune cells were independent negative prognostic markers in long-term overall survival of patients with vulvar cancer. These results show an influence of immune cell infiltration for vulvar carcinoma patients. Immune cell infiltration and immune checkpoint expression may, therefore, become interesting targets for further research on new vulvar cancer treatment strategies.

论文信息

作者
Ansorge N、Dannecker C、Jeschke U、Schmoeckel E、Heidegger HH、Vattai A、Burgmann M、Czogalla B
单位
Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistrasse 15, 81337 Munich, Germany.Germany
期刊
International journal of molecular sciences2022 Apr 22
原文标识
PubMed 35563052 · DOI 10.3390/ijms23094662